The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe below. [newsletters_subscribe form=1]

On a website of the US National Institutes of Health many ongoing clinical studies are listed. Please note that this list is not complete. For more studies please click here.

Here are some of the many current clinical studies.

THC / Dronabinol / Marinol
Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia

at Hadassah Medical Organization, Jerusalem, Israel.

Nabilone / Cesamet
Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis
at University of Manitoba, Winnipeg, Canada.

Nabiximols / Sativex
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
in the United States, the UK and Germany.

Cannabidiol (CBD)
Cannabidiol for Inflammatory Bowel Disease
at Meir Medical Center, Kefar Saba, Israel.

Smoked / Inhaled Cannabis
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
at New York State Psychiatric Institute, USA.

Effects of Vaporized Marijuana on Neuropathic Pain
at CTSC Clinical Research Center, Sacramento, United States.

IACM Bulletin News

  • Cannabis may have a beneficial effect on patients with fibromyalgia

    In a study with 26 patients with fibromyalgia, who had been treated at two hospitals in Israel (Laniado Hospital in Kiryat Sanz and Nazareth Hospital in Nazareth) cannabis improved their symptoms. Their mean age was 37.8 years and mean dosage of cannabis was 26 g per month. All participants completed a questionnaire for the assessment of fibromyalgia severity (Revised Fibromyalgia Continue Reading

    ...more >
  • Cannabis is effective in alleviating symptoms of cancer patients

    A group of Israeli scientists analysed data of 2970 cancer patients treated with medical cannabis between 2015 and 2017 and found beneficial effects across many symptoms. Average age was 59.5 years and 54.6% were women. About one quarter (26.7%) had previous experience with the drug. The most frequent types of cancer pertained to breast (20.7%), lung (13.6%), pancreas (8.1%) and Continue Reading

    ...more >
  • The Ambassadorship Program is open for applications

    On behalf of the IACM Network Committee, we are happy to announce that the Ambassadorship Program of the IACM has been relaunched. The aim of this program is to create a network of representatives around the world, who on the one side like to get support from the IACM for their work in their country and on the other side Continue Reading

    ...more >
  • IACM-Bulletin of 10 January 2016

    Germany: The government presents a draft for a law, which would make cannabis flowers available on prescription by every doctor and force health insurances to reimburse cannabis-based medicines in certain cases Science/Human: Cannabidiol reduces seizure frequency in epilepsy of children and young adults according to open clinical study Science/Human: Pre-treatment with CBD did not influence effects of smoked cannabis News in brief

    ...more >
  • Netanyahu stops medical cannabis export

    Prime Minister Benjamin Netanyahu said US President Donald Trump called and expressed his objection to Israeli exports of cannabis. Channel 2 News reported that Israel will forgo its plans to become a pioneer medical cannabis exporter for fear of upsetting Trump. Jerusalem Post of 7 February 2018

    ...more >
 

Contact us

For questions please use the adjacent form to contact us. We will answer your query as soon as possible.



Print Friendly, PDF & Email